ulmonary arterial hypertension (PAH) is a rare disease of poor prognosis. Recently, continuous intravenous epoprostenol (EPO) was introduced as a treatment for PAH with the consequent improvement of the patients' quality of life. 1 Although therapy with EPO improves the patients' exercise capacity and prognosis, various complications related to the central venous catheters arise during long-term treatment with EPO. 2,3 Among them, catheter-related infection is a serious problem, because the infections aggravate the primary disease.The incidence of catheter-related infections was reported to be 0.3-9.1 infections per 1,000 patient-days in patients with long-term, indwelling central venous catheters for various diseases. [4][5][6] According to a recent report by Oudiz et al, at least 10% of their patients with a catheter infection required admission to critical care wards and several patients died as a direct consequence of the catheter infection, although the incidence of catheter-related infections in patients with PAH receiving EPO was lower than that in patients with other diseases. It has already been reported that the catheter hub was the most important source of catheter-related infections 8,9 and thus several closed hub systems have been introduced. 10,11 In the present study, we adopted the closed hub system for patients with PAH receiving EPO to prevent bacterial invasion from the catheter hub.
Methods
Closed Hub SystemWe introduced the closed hub system after March 2002. This system consists of 2 parts (Fig 1). One part is the Hickman catheter connected to an extension tube (Figs 1A, B,D), and the other part is the infusion port for EPO in medication baggage (Fig 1C). The connection between the Hickman catheter and extension tube is a commercially available catheter connection system (I-system; Nipro Corporation, Japan). The I-system consists of an I-plug (a cap with a latex end injection plug with a male screw) and an I-set (a 21-gauge needle with a Luer -Lock female screw) (Fig 1B). The I-plug is applied to the hub of the Hickman catheter (Fig 1A). The needle of the I-set is inserted into the latex end of the I-plug. Then, the I-plug and I-set are fixed together by the Luer -Lock. The infusion port for EPO in the medication baggage consists of a plug made of latex (Fig 1C).
Study PopulationFrom Background Most of the patients with pulmonary arterial hypertension (PAH) receiving intravenous epoprostenol have experienced catheter-related infections during long-term treatment. Catheter hub was reported to be the most important source of catheter-related infections. To prevent the catheter-related infections, we have introduced a closed hub system and compared the incidence of catheter-related infections with that in patients using a non-closed hub system.
Methods and ResultsWe evaluated the results obtained on 24 occasions in 20 patients with PAH between June 1999 and December 2005. On 11 occasions, a non-closed hub system was used and on 13 cases a closed hub system. We classified the catheter-related ...